oral semaglutide 50 mg VisualAbstract:Oral effectively reduces bodyweight in non-diabetic adults with obesity oral semaglutide 50 mg These

Research shows semaglutide preferentially reduces this harmful fat depot, lowering metabolic disease risk

#GLP1 #HealthyLiving

Frmjar hjrt- och krlhlsa: Stdjer hlsosamma kolesterol- och triglyceridniver samt blodtryck

GLP-1 medications like semaglutide and tirzepatide show mixed effects on gastrointestinal symptoms, with potential benefits for some IBS patients but also the risk of worsening symptoms in others

Purpose of Review Hypertension is the leading modifiable risk factor for cardiovascular disease

Over time this can cause insulin resistance, metabolic disruption - including weight gain, elevated blood sugars and